Peptide News

The emergence of bacterial antibiotic resistance against limited therapeutic options is prompting research into the discovery and optimization of alternative therapies such as cyclic antimicrobial peptides.

Scientists at the Tisch Cancer Institute developed an immunotherapy based on intra-tumor administration of Flt3L and the oncolytic Newcastle Disease Virus (NDV) to improve recruiting and activating dendritic cells.

Learn how investigators at George Washington University Cancer Center leveraged synthetic peptides to activate and amplify patient-derived T cells to generate specific T cell immunotherapies for medulloblastoma.

uncovering-immunogenic-peptides-of-clinical-significance-in-crispr-cas9

SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

Learn about how vaccine or infection-induced T cell responses against the original SARS-CoV-2 strain remain protective against new variants.

Learn about a new approach to the treatment of Parkinson's disease alpha-synuclein pathology that uses a cell-penetrating peptide to induce proteasome degradation of alpha-synuclein.

Non-Coding Sequences Expand Neoantigens for Therapy

How the Proteasome Modulates the Immunopeptidome

α-Hemolysin derived from Staphylococcus aureus Promotes Inflammation Resolution through Generation of Specialized Pro-resolving Mediators